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In the last few years interest in the normal physiology and
disease pathology of the ovary has increased. A search of
bibliographical records carried out without limits for lan-
guage and type of article, inserting only "ovary" as a key
word, produced a total number of 101,414 published arti-
cles, of which 3,040 were published last year.
Such studies have been disseminated to a diffuse subset of
journals, which handle studies related to the ovary but are
not specialized on the subject. In fact, presently, there is
no journal dedicated to covering the extensive research
carried out into ovarian functions and possible interac-
tions with other systems regulating the correct function of
the female organism. On this basis, it has been difficult to
gain a full view of the overall progress and to appreciate
the associations within the fields that could predicate pro-
ductive linkages. As for the case of five blind men and the
elephant, a larger understanding of the field's evolution
has remained elusive owing to focused studies, reported
diversely, which ignored the fields' expansion in its
entirety.
The need to launch a new journal having ovarian biology/
pathology (gender physiopathology) as its only field of
interest was a consequence of these considerations.
Accordingly, Journal of Ovarian Research aims to face open
questions in ovarian biology/pathology using experimen-
tal, translational and clinical approaches.
The journal will certainly cover research relevant to the,
already well-known, reproductive functions of the ovary.
In addition, in the last few years, interesting research has
been carried out with the aim to investigate the function
of the ovary as an endocrine organ; one must consider the
intricate signalling networks at ovary level mediated by
various paracrine and endocrine factors regulating follicu-
lar growth and hormone secretion. Studies in this area will
be welcomed by the journal.
Research in the area of ovarian cancer is also of great inter-
est. In demonstration of increasing interest on the subject
is the creation of ultra-specialised centres for diagnosis
and treatment of ovarian cancer. Due to the specific famil-
iar and genetic traits of ovarian cancer, various studies
have been conducted on possible risk factors and innova-
tive therapies. In particular, in the last few years numerous
studies have been carried out to investigate the role of
benignant pathologies in the risk of ovarian cancer, such
as endometriosis and polycystic ovarian syndrome. Some
studies seem to indicate hormonal therapy for menopause
(hormone replacement therapy, HRT) and drugs for ovu-
lation induction (clomiphene citrate and gonadotropins)
as possible factors, which increase, through unclear mech-
anisms, the risk of ovarian cancer. On the other hand,
among the non-contraceptive benefits of estroprogestin
compounds, an oncological protective effect on ovarian
tissues was acknowledged.
Lastly, but no less important, in the last few years various
experimental in-vitro and animal model studies have been
published on topics such as molecular intraovarian regu-
lation, and regulation from other organs; possible onco-
genetic mechanisms; drug effects; the possibility of oocyte
cryoconservation; autologous and heterologous ovarian
tissue transplant and the use of staminal cells. All these
hypotheses and experimental results, which presently
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seem futuristic, and, in some cases, peculiar, could have,
in the following years, a remarkable clinical implication.
Journal of Ovarian Research will therefore provide an
online open access home for research that provides new
insights into ovarian functions as well as prevention and
treatment of diseases afflicting the organ. The Editorial
Board is composed of international experts from various
scientific fields. Authors should submit their manuscripts
directly online via the journal's website. Manuscripts will
be reviewed by expert referees and we aim to give a first
decision within six weeks from submission. Articles
accepted for publication will be published immediately
online, ensuring a fast and efficient process.
Obviously, we are still at the beginning of this ambitious
scientific-editorial enterprise, and we recognize that with
the profusion of new journals, it may be an inauspicious
time for launching a new enterprise of such specialized
scope. However we hope the journal will become a high
quality forum for researchers in the field and will be
indexed rapidly, reaching an adequate impact factor in the
next few years. Moreover, we hope that the journal will be
of support to international scientific societies offering
ample availability to widespread congress proceedings,
guidelines and integrated strategies in research.
Concluding, we hope that this new journal becomes a sta-
ble point of reference for researchers in the field of ovarian
research. A Japanese proverb holds that "One's most
important task in life is to become a useful person". The
task of Journal of Ovarian Research therefore is to become a
useful vehicle for our community of investigators.